Dr Mohamed A. Amr will be participating at the International Conference on Atomic & nuclear Physics held by Scientific Federation. Professor Mohamed A. Amr is invited as Speaker for this conference. State-of-the-art experimental developments for trace and ultratrace measurements of heavy metals and long-lived radionuclides using ICP-MS constitute Prof. Amr’s core research interests and expertise, for which he has conducted major projects. In conjunction with these core research interests, he has conducted work on enriched isotopes and their application in biological systems. New research activities have been initiated at the CLU at Qatar University on the absorption and distribution of labeled anti cancerogenic senelo compounds, soil chemical remediation, soil bioremediation, soil phytoremediation, refinery wastewater treatment, and decontamination of radioactive wastewater using nanoparticles (2008 onward). These projects were made possible by considerable external funding, exceeding 2 million US dollars. A novel method for detecting radioisotopes by ICP-MS, which started at Qatar University, was eventually rewarded with a large NPRP research grant worth almost two million US dollars. Undergraduate students were trained on how to conduct research through the innovative UREP scheme of the Qatar Foundation. Seven such projects were successfully applied for and granted to benefit students.Prof. Amr is editor, international Journal of Physical sciences. He has also provided external review articles for many international journals and has appointed as referee of grant applications (Qatar foundation, SSREP Peer review). Also, Prof. Amr included in Who's Who in Science and Engineering, 11th Edition (2011-2012).

Professor Mohamed A. Amr is going to talk on The Collision/Reaction Cell and its Application in Inductively Coupled Plasma Mass Spectrometry for the Determination of Radioisotopes: A literature reviewInductively coupled plasma mass spectrometry (ICP-MS) is reviewed as an alternative nuclear analytical technique for the determination of radioisotopes. The latest development and utilization of collision and reaction cells in ICP-MS is presented. These cells are used to promote reactive and non-reactive collisions with resultant benefits in interference reduction, isobar separation, and thermalization/focusing of ions in ICP-MS. Novel ion–molecule chemistry schemes, using a variety of reaction gas reagents selected on the basis of thermodynamic and kinetic principles and data, are now designed and empirically evaluated with relative ease, and a significant body of ICP-MS applications now exists in the literature. Results for separations of isobaric overlaps via cation reactions with NO, N2O, O2, CO2, C2H2, and CH3F in an inductively coupled plasma collision/reaction cell mass spectrometer (ICP-CRC-MS) are reviewed.

ICANP-2018 brings along leading scientists, engineers, administrators of firms within the scope of Atomic & physics to exchange data on their current analysis progress. ICANP-2018 has initiated with an excellent Organizing Committee from well-known universities across the world, creating it a specially designed cluster conference which will be covering most aspects and fields of Atomic & physics.

URL- http://scientificfederation.com/atomic-nuclear-physics-2018/

                                         
Dr.Kattesh V. Katti will be participating at the International Conference on Atomic & nuclear Physics held by Scientific Federation Professor Kattesh V. Katti is invited as plenary Speaker for this conference. Globally recognized as the ‘Father of Green Nanotechnology’, Professor Kattesh V. Katti, MSc Ed, PhD, DSc, FRSC, FNAI, Curators’ Professor of Radiology, Director, Institute of Green Nanotechnology, within the Medical School, University of Missouri, Columbia, USA is internationally renowned as a leader in the interconnecting fields of chemistry, radiopharmaceutical sciences, nanotechnology/green nanotechnology and nanomedicine for biomedical applications, specifically for molecular imaging and therapy of living subjects. Dr. Katti has been awarded a number of international awards and citations, which include: Winner of the 2016 'Person of the Year in Science' award. Dr. Katti was selected for this coveted award for his pioneering research in Green Nanotechnology with applications to Nanomedicine and Oncology. Dr. Katti has won the International Hevesy Medal Award (2015) A Global award for excellence in Nuclear Sciences/Nuclear Medicine for his life time contributions in SPECT/CT Imaging, Radiotherapy through radioactive gold nanoparticles; Elected to the fellowship of the National Academy of Inventors (2015) recognizing the discovery of ‘Katti Peptides’ a group of peptides used in biomedical sciences and nanomedicine research. In recognitions of his groundbreaking discoveries of radioactive gold nanoparticles in cancer therapy with implications in theranostics and plethora of original research in SPECT imaging, Dr. Katti has been recognized as One of the ‘25 Most Influential Scientists In Molecular Imaging in the World’ by RT Image. Dr. Katti has received the ‘Father of Green Nanotechnology’ citation by the Nobel Prize Winner Norman Borlaug, and has been bestowed with the Gauss Professorship Hall of Fame From the Gottingen Academy of Sciences.

Professor Kattesh V. Katti is going to talk on Radioactive Gold-198 Nanoparticles In Nanomedicine: Green Nanotechnology and Radiochemical Approaches in Oncology Cancer alone continues to kill more people than AIDS, malaria, and tuberculosis combined. According to the International Agency for Research on Cancer, there were 12.7 million new cancer cases in 2008. The World Health Organization projects that without major breakthroughs in cancer prevention, discovery of new and accurate diagnostic modalities and development of highly effective therapeutic approaches, the global number of deaths from cancer will increase by nearly 80% by 2030, with most occurring in low- and middle-income countries. There are over 100 pharmaceutical formulations approved by the US Food and Drug Administration (FDA) in order to combat this deadly pandemic. Although surgery and radiation treatments are the initial treatments for most cancers, a large number of oncological approaches are being used to control or cure cancer. Today cancer patients have more choices in which treatment or combination of treatments may be used encompassing three areas of emphasis: (a) Chemotherapy, (b) Hormone therapy; (c) Biological treatment. Despite the currently available choice of established anticancer agents for first-line of activity against cancer, effective delivery of chemotherapeutic, hormonal and biological pharmaceuticals to the tumor tissue and cancer cells selectively continues to be the most vexing problems in cancer oncology. Problems associated with effective delivery of cancer drugs pose severe oncological challenges especially when treating solid tumors (sarcomas, carcinomas, and lymphomas) which account for over 85% of all human cancers. Circumventing these problems is not easy because molecular and cellular biology of neoplastic cells alone has failed to explain the non-uniform uptake of these agents in solid tumors. Repeated delivery of cancer drugs leads to systemic toxicity creating major collateral adverse effects where cancer cells mutate making them resistant to chemotherapeutic treatments. Therefore, the discovery of new drug delivery approaches that effectively penetrate extracellular compartments consisting of vascular and interstitial valves within solid tumors is of profound importance.

ICANP-2018 brings along leading scientists, engineers, administrators of firms within the scope of Atomic & physics to exchange data on their current analysis progress. ICANP-2018 has initiated with an excellent Organizing Committee from well-known universities across the world, creating it a specially designed cluster conference which will be covering most aspects and fields of Atomic & physics.

URL- http://scientificfederation.com/atomic-nuclear-physics-2018/

                                   
Dr.Shiwei Yan will be participating at the International Conference on Atomic & nuclear Physics held by Scientific Federation.Professor Shiwei Yan is invited as Speaker for this conference.Shiwei Yan has completed his PhD from Ibaraki University of Japan and continued with postdoctoral studies for two years at GSI Helmholtzzentrum für Schwerionenforschung in Darmstadt. He had been a senior scientific investigator of theoretical nuclear physics at China Institute of Atomic Energy from 1983 through 1997. From 2004, Dr. Shiwei Yan has been a full professor of theoretical physics at Beijing Normal University. His research interests are predominantly in theoretical nuclear physics, and also in statistical physics and nonlinear dynamics.

Dr Shiwei Yan is going to talk on Fast Ternary Fission: A New Decay Mode of Fissioning Systems a new reaction mechanism of violent separation of the heavy NN systems into three or four massive fragments has been observed in various reaction systems. This fast ternary breakup is considered as a transition from a low-energy deep-inelastic collision into high-energy fragmentation. The study of this new reaction mechanism can reveal some very interesting phenomena of the dynamics of HICs, mechanisms of energy dissipation, dynamical effects and entrance channel hierarchy, nuclear structural effects, and so on.In this talk, He briefly review the main results of such studies, for example, the effects of large mass transfer and statistical decay on a ternary breakup, dynamical effects, time scale, etc.

ICANP-2018 brings along leading scientists, engineers, administrators of firms within the scope of Atomic & physics to exchange data on their current analysis progress. ICANP-2018 has initiated with an excellent Organizing Committee from well-known universities across the world, creating it a specially designed cluster conference which will be covering most aspects and fields of Atomic & physics.

URL-http://scientificfederation.com/atomic-nuclear-physics-2018/

Dr. Yuri Penionzhkevich will be participating at the International Conference on Atomic & nuclear Physics held by Scientific Federation. Professor . Yuri Penionzhkevich is invited as Speaker for this conference. Professor Yu. E. Penionzhkevich works at the Flerov Laboratory of Nuclear Reactions of the Joint Institute for Nuclear Research since 1965 after graduating from the Faculty of Physics of the Voronezh State University. He is a leading scientist in the field of atomic and heavy ion physics. With his participation, many important results were obtained for the first time on the mechanism of heavy-ion induced reactions, on the synthesis and properties of new nuclei close to the limits of stability. Under his supervision new physical setups were designed and put into operation at the beams of the heavy ion cyclotrons in Dubna, as well as for joint experiments at heavy ion beams provided in world centers like GANIL (France), VICKSI (Germany), RIKEN (Japan), CL (Finland). In 1968 a series of investigations on the fission of heavy nuclei was awarded the State Premium for young scientists. Yu.Penionzhkevich is the co-author of the discovery of the new element 106 of the Mendeleev Periodic Table.Starting in 1979 up till now he is the head of a scientific department in the Flerov Laboratory of Nuclear Reactions, where several fundamental results were obtained on the synthesis and properties of exotic nuclei. From 1989 till 1997 he was scientific deputy director of the Laboratory. Professor Yu. E. Penionzhkevich is a well-known scientist. He has been elected in the Council of the National Center GANIL .